DekaBank Deutsche Girozentrale - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$486,000
+109.5%
13,0000.0%0.00%
+100.0%
Q4 2020$232,000
+68.1%
13,000
-43.0%
0.00%0.0%
Q2 2019$138,000
-96.6%
22,800
-92.0%
0.00%
-95.8%
Q1 2019$4,019,000
+4043.3%
284,200
+2393.0%
0.02%
+2300.0%
Q4 2018$97,000
-97.6%
11,400
-96.0%
0.00%
-95.8%
Q3 2018$4,019,000
+1718.6%
284,200
+1901.4%
0.02%
+2300.0%
Q2 2018$221,000
-95.0%
14,200
-94.8%
0.00%
-96.7%
Q1 2018$4,456,000
+19.8%
274,200
+110.1%
0.03%
+3.4%
Q4 2017$3,721,0000.0%130,5000.0%0.03%0.0%
Q3 2017$3,721,000
-9.6%
130,5000.0%0.03%
-12.1%
Q2 2017$4,116,000
+672.2%
130,500
+800.0%
0.03%
+560.0%
Q1 2017$533,000
-32.4%
14,500
-7.6%
0.01%
-37.5%
Q4 2016$788,000
+4.8%
15,700
+8.3%
0.01%0.0%
Q3 2016$752,000
+24.5%
14,5000.0%0.01%
+14.3%
Q2 2016$604,000
+28.5%
14,500
+22.9%
0.01%
+16.7%
Q1 2016$470,000
-13.8%
11,800
-9.9%
0.01%0.0%
Q4 2015$545,000
+173.9%
13,100
+1.6%
0.01%
+200.0%
Q3 2015$199,000
-34.3%
12,900
+5.7%
0.00%
-50.0%
Q2 2015$303,000
+13.5%
12,200
+4.3%
0.00%
+33.3%
Q1 2015$267,00011,7000.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders